TABLE 2.
MetS component | Outcome parameter | OR | 95% CI |
Severity | 1.38 | 0.73–2.58 | |
Mortality | 1.06 | 0.38–2.96 | |
Local complications | 0.99 | 0.72–1.37 | |
Fluid collection | 1.05 | 0.75–1.48 | |
Pseudocyst | 0.85 | 0.50–1.44 | |
OB | Necrosis | 1.48 | 0.89–2.45 |
New onset of diabetes | 1.52 | 0.73–3.14 | |
Systemic complication | 1.35 | 0.79–2.30 | |
Respiratory failure | 1.52 | 0.77–3.02 | |
Heart failure | 2.45 | 0.88–6.78 | |
Renal failure | 2.98 | 1.33–6.66 | |
Severity | 3.41 | 1.39–8.37 | |
Mortality | 4.50 | 0.91–22.20 | |
Local complications | 1.22 | 0.85–1.75 | |
Fluid collection | 1.42 | 0.97–2.08 | |
Pseudocyst | 1.55 | 0.85–2.81 | |
HT | Necrosis | 1.36 | 0.76–2.43 |
New onset of diabetes | 1.56 | 0.66–3.65 | |
Systemic complication | 2.64 | 1.27–5.51 | |
Respiratory failure | 1.59 | 0.63–4.00 | |
Heart failure | 1.41 | 0.36–5.54 | |
Renal failure | 7.46 | 1.61–34.49 | |
Severity | 1.40 | 0.73–2.67 | |
Mortality | 0.61 | 0.19–2.00 | |
Local complications | 1.51 | 1.10–2.07 | |
Fluid collection | 1.32 | 0.94–1.84 | |
Pseudocyst | 1.58 | 0.95–2.61 | |
HL | Necrosis | 1.06 | 0.63–1.78 |
New onset of diabetes | 2.55 | 1.26–5.19 | |
Systemic complication | 1.34 | 0.77–2.32 | |
Respiratory failure | 0.90 | 0.43–1.90 | |
Heart failure | 1.59 | 0.54–4.67 | |
Renal failure | 1.93 | 0.85–4.38 | |
Severity | 0.48 | 0.20–1.16 | |
Mortality | 0.46 | 0.10–2.14 | |
Local complications | 0.84 | 0.56–1.28 | |
Fluid collection | 1.02 | 0.67–1.56 | |
Pseudocyst | 1.01 | 0.53–1.91 | |
DM | Necrosis | 0.53 | 0.24–1.14 |
New onset of diabetes | N/A | N/A | |
Systemic complication | 0.92 | 0.48–1.74 | |
Respiratory failure | 1.48 | 0.68–3.20 | |
Heart failure | 0.32 | 0.07–1.53 | |
Renal failure | 0.43 | 0.15–1.22 |
OB is an independent predictive factor for renal failure; HT for severity; and systemic complications, renal failure, and hyperlipidemia for local complications and for a new diagnosis of diabetes mellitus. OR, odds ratio; CI, confidence interval. Statistically significant values (ORs with CIs) are marked in bold digits.